Skip to main content
. 2021 Dec 21;16(12):e0261690. doi: 10.1371/journal.pone.0261690

Table 1. Characteristics of 219 hemochromatosis probands with HFE p.C282Y homozygositya.

Characteristic Cirrhosis (n = 22) No cirrhosis (n = 197) Value of p
Male, % (n) 86.4 (19) 53.8 (106) 0.0030
Mean age at diagnosis, y, ± 1 SD 52 ± 9 48 ± 14 0.0451
Diabetes, % (n)b 22.7 (5) 14.2 (28) 0.3417
Heavy alcohol consumption, % (n) 22.7 (5) 5.1 (10) 0.0099
Abdominal pain, % (n) 22.7 (5) 1.5 (3) 0.0003
Abdominal tenderness, % (n) 13.6 (3) 2.0 (4) 0.0238
Hepatomegaly, % (n) 45.5 (10) 12.2 (24) 0.0004
Splenomegaly, % (n) 13.6 (3) 1.0 (2) 0.0078
NAFLD, % (n) 27.3 (6) 21.8 (43) 0.5914
Chronic viral hepatitis, % (n)c 18.2 (4) 1.5 (3) 0.0022
Ascites, % (n) 4.8 (1) 0.5 (1) 0.1912
Mean hemoglobin, g/L, ± 1 SD 140 ± 18 147 ± 15 0.1559
Median TS, % (n) (range) 89 (34, 100) 70 (19, 100) 0.0235
Median SF, μg/L (range) 2000 (387, 5613) 650 (15, 6103) <0.0001
Median QFe, g (range) 6.3 (1.0, 31.2) 2.6 (0, 30.0) <0.0001

aAbbreviations: NAFLD, non-alcoholic fatty liver disease; QFe, quantity of iron removed by phlebotomy to achieve iron depletion; SD, standard deviation; SF, serum ferritin; TS, transferrin saturation.

bThirty-one probands had type 2 diabetes. Two other probands had type 1 diabetes.

cFive probands had chronic viral hepatitis C. Two other probands had chronic viral hepatitis B. No proband was treated with anti-viral therapy for chronic viral hepatitis before diagnosis of hemochromatosis.